Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

20 for 2020 – Five pharma leaders to watch in 2020

Five individuals we think will have a key role to play in the sector in 2020 and beyond

Courageous Conversations ep.5: Virtual Meetings During the COVID-19 Pandemic

Impetus Digital

Impetus Digital official statement on COVID-19

At Impetus Digital, the health and wellbeing of our staff, clients, advisors, and their families is always our top priority. Recently, we have seen high numbers of advisors cancel their...

Impetus Digital

“New models” for agency pitching. My “Top takeaways” from the PM Society event

Paul Morrissey, Global Business Director, OPEN Health

OPEN Health

- PMLiVE

Mapping the clinical and emotional journey to better understand lived experience

Written by OPEN Health's Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew

OPEN Health

- PMLiVE

Biogen joins COVID-19 efforts with $10m support fund

Funds will be used to address 'immediate critical needs'

- PMLiVE

First patients dosed with Moderna’s COVID-19 vaccine

More pharma players also join vaccine development efforts

- PMLiVE

Novo Nordisk hits pause on rival to Hemlibra for haemophilia

Halts three studies because of safety concerns

- PMLiVE

UK ramps up measures to combat coronavirus spread

New advice encourages ‘social-distancing’ as cases expected to soar

- PMLiVE

Why pharma should invest in the education of doctors

By Tim Russell, Heather Hancock and Deepak Jadon

- PMLiVE

For those who love science and storytelling — consider medical writing

In NetworkPharma’s latest career guide for wannabe medical writers, Kat Schleicher discusses how her love of science and storytelling makes medical writing the perfect career choice for her:​I love science!...

Lucid Group Communications Limited

- PMLiVE

Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19

The interleukin-6 inhibitor will be evaluated in critically ill patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links